Skip to content

Effects of Andiroba Extract Oil on the Gingival Inflammaton

Effect of Carapa guianensis Extract Gel on Dental Plaque (periodontopathogenic microorganisms) and Gingival Inflammation in patients undergoing fixed orthodontic treatment: a prospective split-mouth study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
REBEC
Registry ID
RBR-25v5wjf
Enrollment
Unknown
Registered
2026-01-06
Start date
2025-11-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis and periodontal diseases

Interventions

This is a randomized, controlled, parallel-group, two-arm clinical trial with double masking. A total of 30 participants will be included and allocated into two groups: the Intervention Group with 15
the remaining components will correspond to the orabase vehicle (acetic acid, chitosan, and Milli-Q water, in a quantity sufficient to). The test gel will be applied to the teeth three times a day for

Sponsors

Universidade Federal do Pará
Lead Sponsor
Universidade Federal do Pará
Collaborator

Eligibility

Age
12 Years to 17 Years

Inclusion criteria

Inclusion criteria: Age between 12 and 17 years; both sexes; Must sign the research information letter and Informed Consent Form; must not have systemic alterations; normal cognitive and motor development; index teeth present: 13, 14, 15, 23, 24 and 25; must have class I malocclusion: crowding of anterior teeth, no crossbites and with coronal exposure for bonding of braces

Exclusion criteria

Exclusion criteria: Antibiotic treatment within 1 month prior to the evaluation; use of any medications that may affect gingival tissue; systemic diseases or conditions that may interfere with the study results (immunodeficiency, uncontrolled diabetes, hematological diseases, genetic conditions, deficiencies); presence of orthopedic orthodontic appliances and/or space maintainers; mucosal diseases; severe oropharyngeal infections; extensive caries in any tooth

Design outcomes

Primary

MeasureTime frame
Variation in the percentage of sites with bleeding on probing, evaluated on day 0 and day 28, by a single examiner, in the disto-vestibular, mid-vestibular and mesio-vestibular sites, comparing the side that received andiroba gel containing 50% Carapa guianensis with the side that received placebo gel.

Secondary

MeasureTime frame
No secondary outcomes are expected.

Countries

Brazil

Contacts

Public ContactFabricio LIma

Universidade Federal do Pará

fvpl@hotmail.com+55(91)991277077

Outcome results

None listed

Source: REBEC (via WHO ICTRP)